Evidence map›Paper›PMID 9722627›Full record

ArticleNucleic acids research1998

The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bbcl-2 gene expression.

M D Smith, S J Dawson, L M Boxer, D S Latchman

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

M D SmithDepartment of Molecular Pathology, Windeyer Institute of Medical Sciences, University College London,Cleveland Street, London W1P 6DB, UK and Department of Medicine, Stanford University Medical Center, Stanford, CA 94305-5112, USA.
S J Dawson
L M Boxer
D S Latchman
University College London · GB

Funding

ACTIVATION OF BCL-2 IN HEMATOLOGIC MALIGNANCIESR01CA056764 · NCI · STANFORD UNIVERSITY · PI BOXER, LINDA M · 1993 to 2012
$3.3M
Activation of BCL-2 in Hematologic MalgnanciesR56CA056764 · NCI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI BOXER, LINDA M · 2007 to 2007
$295k
NCI NIH HHS CA56764
6 · The paper itself

Abstract

The ability of the POU family transcription factor Brn-3a to stimulate neurite outgrowth and the expression of the genes encoding neuronal proteins such as the neurofilaments and SNAP-25 has previously been shown to be dependent upon the C-terminal POU domain which can mediate both DNA binding and transcriptional activation. We show here, however, that the ability of Brn-3a to activate Bcl-2 expression and protect neuronal cells from apoptosis (programmed cell death) requires a distinct N-terminal activation domain. Bcl-2 gene activation and protection from apoptosis are thus produced only by the long form of Brn-3a which contains this domain and not by a naturally occurring short form lacking this domain or by the isolated POU domain, although all these forms of Brn-3a can stimulate neurite outgrowth. Hence Brn-3a is a multi-functional transcription factor with different regions of the factor mediating its different effects and two distinct forms with different properties being generated by alternative splicing.

Indexed as

ApoptosisGene Expression RegulationGenes, bcl-2AnimalsCell CycleCell LineDNA-Binding ProteinsHumansKineticsNeuronsProto-Oncogene Proteins c-bcl-2Recombinant Fusion ProteinsRecombinant ProteinsTranscriptional ActivationTranscription Factor Brn-3Transcription Factor Brn-3ADNA-Binding ProteinsPOU4F1 protein, humanProto-Oncogene Proteins c-bcl-2Recombinant Fusion ProteinsRecombinant ProteinsTranscription Factor Brn-3Transcription Factor Brn-3ATranscription Factors

Identifiers

PMID9722627
PMCPMC147830
OpenAlexW2039429644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.